Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy NantHealth stock | 2.19

Own NantHealth stock in just a few minutes.


Fact checked

NantHealth, Inc is a health information services business based in the US. NantHealth shares (NH) are listed on the NASDAQ and all prices are listed in US Dollars. NantHealth employs 398 staff and has a trailing 12-month revenue of around USD$91.6 million.

How to buy shares in NantHealth

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for NantHealth. Find the stock by name or ticker symbol: NH. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until NantHealth reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$2.19, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of NantHealth, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of NantHealth. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted NantHealth's share price?

Since the stock market crash in March caused by coronavirus, NantHealth's share price has had significant positive movement.

Its last market close was USD$2.19, which is 13.24% up on its pre-crash value of USD$1.9 and 99.09% up on the lowest point reached during the March crash when the shares fell as low as USD$1.1.

If you had bought USD$1,000 worth of NantHealth shares at the start of February 2020, those shares would have been worth USD$780.49 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$1,335.37.

NantHealth share price

Use our graph to track the performance of NH stocks over time.

NantHealth shares at a glance

Information last updated 2020-11-30.
Latest market close USD$2.19
52-week range USD$0.811 - USD$6.39
50-day moving average USD$2.2574
200-day moving average USD$3.1628
Wall St. target price USD$3.75
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.651

Buy NantHealth shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Stocks, Mutual funds, ETFs, Forex
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy NantHealth stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

NantHealth price performance over time

Historical closes compared with the close of $2.19 from 2020-11-16

1 week (2020-11-20) N/A
1 month (2020-10-30) 8.96%
3 months (2020-08-28) N/A
6 months (2020-05-28) N/A
1 year (2019-11-27) N/A
2 years (2018-11-27) N/A
3 years (2017-11-27) N/A
5 years (2015-11-27) N/A

NantHealth financials

Revenue TTM USD$91.6 million
Gross profit TTM USD$62.2 million
Return on assets TTM -5.72%
Return on equity TTM 0%
Profit margin -52.36%
Book value $-0.276
Market capitalisation USD$261.3 million

TTM: trailing 12 months

Shorting NantHealth shares

There are currently 1.5 million NantHealth shares held short by investors – that's known as NantHealth's "short interest". This figure is 2.3% down from 1.6 million last month.

There are a few different ways that this level of interest in shorting NantHealth shares can be evaluated.

NantHealth's "short interest ratio" (SIR)

NantHealth's "short interest ratio" (SIR) is the quantity of NantHealth shares currently shorted divided by the average quantity of NantHealth shares traded daily (recently around 182773.75296912). NantHealth's SIR currently stands at 8.42. In other words for every 100,000 NantHealth shares traded daily on the market, roughly 8420 shares are currently held short.

However NantHealth's short interest can also be evaluated against the total number of NantHealth shares, or, against the total number of tradable NantHealth shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NantHealth's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 NantHealth shares in existence, roughly 10 shares are currently held short) or 0.0561% of the tradable shares (for every 100,000 tradable NantHealth shares, roughly 56 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against NantHealth.

Find out more about how you can short NantHealth stock.

NantHealth share dividends

We're not expecting NantHealth to pay a dividend over the next 12 months.

NantHealth share price volatility

Over the last 12 months, NantHealth's shares have ranged in value from as little as $0.811 up to $6.39. A popular way to gauge a stock's volatility is its "beta".

NH.US volatility(beta: 1.79)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NantHealth's is 1.7917. This would suggest that NantHealth's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

NantHealth overview

NantHealth, Inc., together with its subsidiaries, operates as a healthcare technology company converging science and technology in the United States, the United Kingdom, Singapore, and Canada. It provides NantHealth solutions, including molecular profiling solutions, software-as-a-service platforms, and connected care medical device interoperability solutions to enable value-based care and evidence-based clinical practice. The company's products include GPS Cancer, a molecular profile that integrates whole genome/exome sequencing of tumor and normal germline samples, as well as whole transcriptome sequencing; GPS Cancer Report, a GPS cancer solution; Liquid GPS, a blood-based molecular laboratory test that provides a tool for noninvasive tumor profiling and quantitative monitoring of treatment response; and Eviti, a decision support solution that provides evidence-based clinical decision support. It also offers web-based and mobile software solutions, such as Device Connectivity Suite, a device connectivity and near real-time biometric software and hardware suite to aggregate data from in-hospital and remote medical devices. In addition, NantHealth, Inc. provides NaviNet Open, a payer-provider collaboration platform comprising plan central, eligibility and benefit, claims status inquiry, claims management, referral, authorization, and document exchange, as well as AllPayer Access services; and systems infrastructure solutions, which include cloud computing, storage, and transport infrastructure. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was founded in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site